<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36744807</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Older black race is a risk factor for metabolic syndrome in cutaneous lupus erythematosus.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>582</EndPage><MedlinePgn>580-582</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231154785</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Henry W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coias</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams-Huet</LastName><ForeName>Beverley</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neeland</LastName><ForeName>Ian J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Harrington Heart and Vascular Institute, Division of Cardiovascular Medicine, University Hospitals Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Benjamin F</ForeName><Initials>BF</Initials><Identifier Source="ORCID">0000-0002-4092-7658</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AR061441</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="N">Black People</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest</b>: Dr. Chong is an investigator for Daavlin Corporation and Biogen Incorporated. He is a consultant for Bristol Meyers Squibb, EMD Serono, Horizon Therapeutics, and Biogen Incorporated. He receives royalties from MAPI Research Trust. The other authors have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36744807</ArticleId><ArticleId IdType="mid">NIHMS1866812</ArticleId><ArticleId IdType="pmc">PMC10121811</ArticleId><ArticleId IdType="doi">10.1177/09612033231154785</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hallajzadeh J, Khoramdad M, Izadi N, et al. The association between metabolic syndrome and its components with systemic lupus erythematosus: a comprehensive systematic review and meta-analysis of observational studies. Lupus 2018; 27: 899&#x2013;912. DOI: 10.1177/0961203317751047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317751047</ArticleId><ArticleId IdType="pubmed">29301471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Qin W, Zhang YH, et al. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis. Int J Rheum Dis 2017; 20: 917&#x2013;928. 2017/08/30. DOI: 10.1111/1756-185X.13153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13153</ArticleId><ArticleId IdType="pubmed">28851080</ArticleId></ArticleIdList></Reference><Reference><Citation>Akarsu S, Ozbagcivan O, Semiz F, et al. High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study. J Immunol Res 2017; 2017: 3972706. 2017/01/28. DOI: 10.1155/2017/3972706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3972706</ArticleId><ArticleId IdType="pmc">PMC5239982</ArticleId><ArticleId IdType="pubmed">28127570</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Panel on Detection E and Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486&#x2013;2497. 2001/05/23. DOI: 10.1001/jama.285.19.2486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.19.2486</ArticleId><ArticleId IdType="pubmed">11368702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ES, Giles WH and Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356&#x2013;359. 2002/01/16. DOI: 10.1001/jama.287.3.356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.287.3.356</ArticleId><ArticleId IdType="pubmed">11790215</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker B, Urowitz MB, Gladman DD, et al. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 2015; 74: 1530&#x2013;1536. 2014/04/03. DOI: 10.1136/annrheumdis-2013-203933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203933</ArticleId><ArticleId IdType="pmc">PMC4515988</ArticleId><ArticleId IdType="pubmed">24692585</ArticleId></ArticleIdList></Reference><Reference><Citation>Munguia-Realpozo P, Mendoza-Pinto C, Sierra Benito C, et al. Systemic lupus erythematosus and hypertension. Autoimmun Rev 2019; 18: 102371. 2019/08/16. DOI: 10.1016/j.autrev.2019.102371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102371</ArticleId><ArticleId IdType="pubmed">31415907</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly P, Buyon J, Belmont HM, et al. Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program. Lupus Sci Med 2019; 6: e000344. 2019/12/05. DOI: 10.1136/lupus-2019-000344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2019-000344</ArticleId><ArticleId IdType="pmc">PMC6827754</ArticleId><ArticleId IdType="pubmed">31798917</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>